CytomX Therapeutics, Inc. (CTMX)
NASDAQ: CTMX · IEX Real-Time Price · USD
1.320
-0.010 (-0.75%)
At close: Jul 2, 2024, 4:00 PM
1.260
-0.060 (-4.55%)
After-hours: Jul 2, 2024, 7:39 PM EDT
CytomX Therapeutics Market Cap
CytomX Therapeutics has a market cap or net worth of $102.85 million as of July 2, 2024. Its market cap has increased by 0.64% in one year.
Market Cap
102.85M
Enterprise Value
-35.48M
1-Year Change
0.64%
Ranking
Category
Stock Price
$1.32
Market Cap Chart
Since October 8, 2015, CytomX Therapeutics's market cap has decreased from $464.70M to $102.85M, a decrease of -77.87%. That is a compound annual growth rate of -15.85%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 1, 2024 | 103.60M | -0.19% |
| Dec 29, 2023 | 103.80M | -1.80% |
| Dec 30, 2022 | 105.70M | -62.58% |
| Dec 31, 2021 | 282.50M | -6.70% |
| Dec 31, 2020 | 302.80M | -19.81% |
| Dec 31, 2019 | 377.60M | -44.44% |
| Dec 31, 2018 | 679.60M | -16.18% |
| Dec 29, 2017 | 810.80M | 102.65% |
| Dec 30, 2016 | 400.10M | -46.78% |
| Dec 31, 2015 | 751.80M | 61.78% |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Journey Medical | 104.87M |
| Oramed Pharmaceuticals | 104.62M |
| KORU Medical Systems | 103.88M |
| Annovis Bio | 103.67M |
| Immunic | 103.59M |
| InflaRx | 101.87M |
| Zentek | 101.44M |
| FONAR | 100.62M |